Paper41865130
ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability.
Farnsworth DA and 4 others. Cell Mol Life Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability. Papers, record 41865130. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41865130
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Extracellular Signal-Regulated MAP Kinases | Major topic |
| MAP Kinase Signaling System | Major topic |
| Humans | |
| Animals | |
| Oncogenes | |
| Signal Transduction | |
| Carcinogenesis | |
| Molecular Targeted Therapy | |
| Antineoplastic Agents |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PJS-186324 and PJT - 169129 | Institute of Cancer Research | PubMed | ||
| Project Grant | Terry Fox Research Institute | PubMed |
Source PubMed
References199
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36686779 | Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models. | Front Oncol | 2022 | https://conductscience.org/library/papers/36686779 | PubMed |
| 2 | 38754355 | The mitogen-activated protein kinase network, wired to dynamically function at multiple scales. | Curr Opin Cell Biol | 2024 | https://conductscience.org/library/papers/38754355 | PubMed |
| 3 | 16273091 | BRAF mutation predicts sensitivity to MEK inhibition. | Nature | 2006 | https://conductscience.org/library/papers/16273091 | PubMed |
| 4 | 21871886 | The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. | Exp Cell Res | 2011 | https://conductscience.org/library/papers/21871886 | PubMed |
| 5 | 40394416 | Erk1R84H is an oncoprotein that causes hepatocellular carcinoma in mice and imposes a rigorous negative feedback loop. | Oncogene | 2025 | https://conductscience.org/library/papers/40394416 | PubMed |
| 6 | 11278920 | Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278920 | PubMed |
| 7 | 32171687 | Oncogene-induced senescence: From biology to therapy. | Mech Ageing Dev | 2020 | https://conductscience.org/library/papers/32171687 | PubMed |
| 8 | 7775407 | Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7775407 | PubMed |
| 9 | 38600345 | The phosphatase inhibitor LB-100 creates neoantigens in colon cancer cells through perturbation of mRNA splicing. | EMBO Rep | 2024 | https://conductscience.org/library/papers/38600345 | PubMed |
| 10 | 26416458 | KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy. | Oncotarget | 2015 | https://conductscience.org/library/papers/26416458 | PubMed |
| 11 | 19578332 | Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages. | Nat Chem Biol | 2009 | https://conductscience.org/library/papers/19578332 | PubMed |
| 12 | 17496918 | The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. | Oncogene | 2007 | https://conductscience.org/library/papers/17496918 | PubMed |
| 13 | 19228121 | Dual-specificity phosphatases: critical regulators with diverse cellular targets. | Biochem J | 2009 | https://conductscience.org/library/papers/19228121 | PubMed |
| 14 | 26047463 | Evidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinoma. | Elife | 2015 | https://conductscience.org/library/papers/26047463 | PubMed |
| 15 | 28039265 | Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28039265 | PubMed |
| 16 | 25320010 | ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors. | Cancer Res | 2014 | https://conductscience.org/library/papers/25320010 | PubMed |
| 17 | 30936125 | Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30936125 | PubMed |
| 18 | 31675495 | Cellular Senescence: Defining a Path Forward. | Cell | 2019 | https://conductscience.org/library/papers/31675495 | PubMed |
| 19 | 20818844 | Inhibition of mutated, activated BRAF in metastatic melanoma. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20818844 | PubMed |
| 20 | 26657151 | Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. | Oncogene | 2016 | https://conductscience.org/library/papers/26657151 | PubMed |
Genes68
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41865130
GET https://conductscience.org/api/papers/v1/41865130/references?page=2